M Pedrazzoni

Author PubWeight™ 26.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 2000 2.46
2 Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab 1996 1.68
3 Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia 2005 1.63
4 Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 1998 1.33
5 Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp Gerontol 2001 1.31
6 Impairment of cytokine production in mice fed a vitamin D3-deficient diet. Immunology 1991 1.13
7 Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. Eur J Endocrinol 2000 1.03
8 Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. Scand J Rheumatol 1998 0.92
9 Ethanol and acetaldehyde inhibit the formation of early osteoblast progenitors in murine and human bone marrow cultures. Alcohol Clin Exp Res 1999 0.89
10 Spontaneous release of interleukin-I and interleukin-6 by peripheral blood mononuclear cells after oophorectomy. Clin Sci (Lond) 1992 0.88
11 Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol 1991 0.86
12 Augmentation of monocyte chemotaxis by 1 alpha,25-dihydroxyvitamin D3. Stimulation of defective migration of AIDS patients. J Immunol 1990 0.86
13 Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis. Bone Miner 1991 0.84
14 Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro. Clin Endocrinol (Oxf) 1999 0.84
15 The comparative effect of ovarian hormone administration on bone mineral status in oophorectomized rats. Bone 1989 0.80
16 Longitudinal study of bone loss after thyroidectomy and suppressive thyroxine therapy in premenopausal women. Acta Endocrinol (Copenh) 1992 0.80
17 [Changes in serum osteocalcin after orthopedic surgery procedures]. G Clin Med 1986 0.79
18 Guidelines for the diagnosis, prevention and management of osteoporosis. Reumatismo 2016 0.78
19 Incidence of hip fracture: an Italian survey. Osteoporos Int 1993 0.78
20 Circulating opioid peptides during thermal stress. Horm Metab Res 1990 0.78
21 [Treatment experience with chronic spinal pain in involutional osteoporosis]. Ann Ital Med Int 1993 0.77
22 Validation and further development of the WHO 10-year fracture risk assessment tool in Italian postmenopausal women: project rationale and description. Clin Exp Rheumatol 2010 0.77
23 [Bisphosphonates stimulate the production of basic fibroblast growth factor and the formation of bone marrow precursors of osteoblasts. New findings about their mechanism of action]. Minerva Med 1998 0.77
24 Antioxidants and bone turnover in involutional osteoporosis. J Endocrinol Invest 2002 0.77
25 Chronic effects of marihuana smoking on luteinizing hormone, follicle-stimulating hormone and prolactin levels in human males. Drug Alcohol Depend 1992 0.76
26 Interleukin-6: a pathogenetic role in the postmenopausal osteoporosis? Acta Biomed Ateneo Parmense 1995 0.76
27 Recombinant interferon alpha (rIFN-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis. Clin Endocrinol (Oxf) 1999 0.76
28 [Sequential calcitriol-calcitonin in the therapy of osteoporosis]. Minerva Endocrinol 1989 0.75
29 Metyrapone effects on beta-endorphin, ACTH and cortisol levels after chronic opiate receptor stimulation in man. Neuropeptides 1990 0.75
30 Salmon calcitonin given by nasal spray or by injection does not increase beta-endorphin levels in normal men. Life Sci 1990 0.75
31 Impaired ACTH and beta-endorphin response to sauna-induced hyperthermia in heroin addicts. Acta Endocrinol (Copenh) 1989 0.75
32 Impaired PRL response to hyperthermia in alcoholic men. Neuropeptides 1992 0.75
33 [New therapeutic trends in osteoporosis: physiopathological bases and clinical aspects]. Recenti Prog Med 1986 0.75
34 [Tissue oxygenation in elderly diabetics]. G Clin Med 1982 0.75
35 Effects of nandrolone decanoate on bone mass in established osteoporosis. Maturitas 1993 0.75
36 [Changes in bone mass with age. Transversal study on a female population using photon densitometry]. Minerva Med 1987 0.75
37 [Hypocalcemia and thyrotoxicosis. Description of a clinical case]. Recenti Prog Med 1987 0.75
38 [Clinical study of a new non-steroid anti-inflammatory agent for rectal administration]. G Clin Med 1982 0.75
39 [New polypeptide hormonal candidates encoded by the calcitonin gene]. Recenti Prog Med 1983 0.75
40 [Hypocalcemia, calcium active hormones and osteocalcin in a case of multiple myeloma]. Recenti Prog Med 1985 0.75
41 [Evaluation of age-related changes of erythrocyte filtration]. Acta Biomed Ateneo Parmense 1983 0.75
42 Calcitonin nasal spray reduces opioid withdrawal syndrome without modification of endogenous opioid secretion. Recenti Prog Med 1992 0.75
43 Spontaneous release of interleukin-1 (IL-1) from medullary mononuclear cells of pagetic subjects. Calcif Tissue Int 1989 0.75
44 [Prevalence of Paget's disease in the province of Parma]. Recenti Prog Med 1994 0.75
45 [Secretion dynamics of prolactin after low dose administration of dexamethasone: comparison between normal, demented and depressed elderly subjects]. G Clin Med 1986 0.75
46 [Effect of ovariectomy on bone mass. Transverse study using photon densitometry]. Minerva Ginecol 1987 0.75
47 [Involutional osteoporosis and basal levels of prolactin]. Medicina (Firenze) 1989 0.75
48 [Noninvasive study of the bone using single- and dual-photon densitometry: effects of age and menopause on bone density of normal and osteoporotic female population]. Acta Biomed Ateneo Parmense 1985 0.75
49 Effects of oophorectomy on trabecular bone mineral content in the rat. Boll Soc Ital Biol Sper 1986 0.75
50 [Effect of estrogen-progesterone treatment on trabecular and cortical bone mineral content in rats]. Minerva Ginecol 1988 0.75
51 [Effects of alpha-calcidiol (1 alpha-hydroxy-cholecalciferol) on the serum levels of osteocalcin in involutional osteoporosis]. Minerva Endocrinol 1990 0.75
52 [The oxyhemoglobin dissociation curve in aged subjects]. G Clin Med 1982 0.75
53 [Mental deterioration in elderly subjects with type II diabetes mellitus]. G Clin Med 1986 0.75
54 Lack of increased serum interleukin-6 and soluble IL-6 receptor concentrations in patients with thyroid diseases following recombinant human interferon alpha therapy. J Investig Med 1996 0.75
55 [Recent studies of a non-collagen protein of bone: osteocalcin]. G Clin Med 1984 0.75
56 [Relation between the metabolic state, tissue oxygenation and diabetic microangiopathy]. G Clin Med 1984 0.75
57 [The hormonal response to hypercalcemic stimulation: the difference between male and female young people]. Acta Biomed Ateneo Parmense 1985 0.75
58 Impaired prolactin response to hyperthermia in heroin addicts. Acta Endocrinol (Copenh) 1990 0.75
59 The pathophysiology of calcitonin in man. Int J Tissue React 1986 0.75
60 Impaired calcitonin secretion following stimulation in spasmophilic women. Biomed Pharmacother 1987 0.75
61 [Calciotrophic hormones and aging]. G Clin Med 1989 0.75
62 [Rehabilitative therapy as prevention against demineralization caused by inactivity in aged hemiplegics]. G Clin Med 1984 0.75
63 [Effects of a short-term treatment with human growth hormone (hGH) on the parameters of phosphorus-calcium metabolism]. Recenti Prog Med 1986 0.75
64 [Parkinson's disease in the elderly: therapeutic note]. G Clin Med 1987 0.75